300529 健帆生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)6.15015.65825.30912.98725.661
总资产报酬率 ROA (%)4.0359.87415.0137.96517.397
投入资产回报率 ROIC (%)4.52011.16316.9088.87119.297

边际利润分析
销售毛利率 (%)77.25078.70180.77979.74182.335
营业利润率 (%)46.59434.33639.04528.28941.320
息税前利润/营业总收入 (%)47.82434.88238.82325.34040.097
净利润/营业总收入 (%)39.35826.42730.41022.14635.359

收益指标分析
经营活动净收益/利润总额(%)97.234101.99395.92396.29392.583
价值变动净收益/利润总额(%)3.9668.1034.2810.0001.034
营业外收支净额/利润总额(%)-0.462-4.644-3.814-4.376-1.244

偿债能力分析
流动比率 (X)8.7065.8123.6303.9934.592
速动比率 (X)7.9685.2313.1903.5294.105
资产负债率 (%)32.99535.82338.05743.12333.713
带息债务/全部投入资本 (%)20.94121.81926.70932.35523.883
股东权益/带息债务 (%)353.839334.058260.957197.769304.068
股东权益/负债合计 (%)203.092179.174162.726131.670195.735
利息保障倍数 (X)33.11316.85232.037-14.371-56.060

营运能力分析
应收账款周转天数 (天)6.3747.4018.62627.77035.460
存货周转天数 (天)193.607264.446252.816339.301223.177